M&A

AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
Wed, 12/6/23 - 09:23 pm
AbbVie
Cerevel Therapeutics
M&A
Neuroscience
PerkinElmer buys Covaris to boost next-gen life sciences offerings
Medical Marketing and Media
Mon, 12/4/23 - 06:07 pm
PerkinElmer
M&A
Covaris
R&D
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive
Mon, 12/4/23 - 10:18 am
Roche
Carmot Therapeutics
weight loss
obesity
M&A
Tang Capital’s Concentra back with another buyout offer, this time for LianBio
Fierce Biotech
Sun, 12/3/23 - 09:39 pm
Concerta
M&A
LianBio
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Medical Marketing and Media
Fri, 12/1/23 - 09:43 am
biotech stocks
AbbVie
Immunogen
M&A
J&J Becomes the Newest Player in the LAA Market
Medical Devices and Diagnostics Industry
Thu, 11/30/23 - 11:21 pm
JNJ
M&A
Medtech
Penditure LAA
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
Cigna, Humana in talks to merge
BioPharma Dive
Wed, 11/29/23 - 11:30 pm
insurers
M&A
Cigna
Humana
Merck Drops Up to $610M on Neuro Disease-Focused Caraway Therapeutics
BioSpace
Tue, 11/21/23 - 12:05 pm
Merck
M&A
neurodegenerative disease
Caraway Therapeutics
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Astellas
Propella Therapeutics
M&A
JNJ
Zytiga
prostate cancer
LENZ Therapeutics and Graphite Bio agree to merge
Pharmaceutical Technology
Thu, 11/16/23 - 10:15 am
Graphite Bio
Lenz Therapeutics
M&A
presbyopia
Pencils down for Graphite, as gene editing biotech merges into vision-loss-focused Lenz
Fierce Biotech
Wed, 11/15/23 - 11:55 am
Lenz Therapeutics
Graphite Bio
gene editing
reverse merger
vision loss
M&A
Catalent delays quarterly filing with SEC on $700 mln impairment charge
Reuters
Tue, 11/14/23 - 11:18 am
Catalent
SEC
M&A
Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut
Reuters
Wed, 11/8/23 - 11:35 am
Biogen
Alzheimer's disease
Leqembi
Reata
M&A
earnings
Roivant’s $7B Roche deal was a ‘moment of opportunity,’ CEO says
BioPharma Dive
Tue, 10/31/23 - 09:32 pm
Roivant
Televant
M&A
Roche
United Therapeutics to Acquire Miromatrix Medical
Yahoo Finance
Mon, 10/30/23 - 10:27 am
United Therapeutics
Miromatrix Medical
M&A
bioengineering
Amgen plans to lay off 350 former Horizon employees after $28B buyout
Fierce Pharma
Tue, 10/24/23 - 07:54 pm
Amgen
Horizon Therapeutics
layoffs
M&A
Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Jazz looks at strategic options, including possible sale or unit divestiture
Fierce Pharma
Fri, 10/20/23 - 11:58 am
Jazz Pharma
Xyrem
M&A
Pfizer wins unconditional EU antitrust okay for $43 billion Seagen buy
Reuters
Thu, 10/19/23 - 10:45 pm
Pfizer
Seagen
M&A
Europe

Pages